{"version":"1.0","provider_name":"Ninewells cancer campaign","provider_url":"https:\/\/sites.dundee.ac.uk\/ncc","title":"Targeted anti-cancer therapy with CDK4\/6 inhibitors in oesophageal and breast cancer - Ninewells cancer campaign","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qdmhVuXq7E\"><a href=\"https:\/\/sites.dundee.ac.uk\/ncc\/targeted-anti-cancer-therapy-with-cdk4-6-inhibitors\/\">Targeted anti-cancer therapy with CDK4\/6 inhibitors in oesophageal and breast cancer<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/sites.dundee.ac.uk\/ncc\/targeted-anti-cancer-therapy-with-cdk4-6-inhibitors\/embed\/#?secret=qdmhVuXq7E\" width=\"600\" height=\"338\" title=\"&#8220;Targeted anti-cancer therapy with CDK4\/6 inhibitors in oesophageal and breast cancer&#8221; &#8212; Ninewells cancer campaign\" data-secret=\"qdmhVuXq7E\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/sites.dundee.ac.uk\/ncc\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"A new class of drugs called CDK4\/6 inhibitors have recently revolutionised breast cancer treatment. They are considerably less toxic than other chemotherapy drugs and yet they can have remarkable effects on tumour growth. This led to their fast-tracked approval in 2015 to treat a major subtype of breast cancer that accounts for 70% of cases [&hellip;]","thumbnail_url":"https:\/\/sites.dundee.ac.uk\/wp-content\/uploads\/sites\/283\/2021\/10\/Eight-2.jpg"}